The Miami Entrepreneur

The Wall Street Journal: J&J to end COVID vaccine manufacturing deal with Emergent Biosolutions

Read Time:9 Second

Johnson & Johnson said Monday it planned to terminate its COVID-19 vaccine supply deal with contract manufacturer Emergent BioSolutions Inc., as both companies accused each other of breaching the agreement.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post The Margin: A new four-day work week experiment begins in the U.K. on June 6 — here’s what to know
Next post The Margin: ‘Scream 6’ not paying Neve Campbell enough to return, says the star of the $744 million horror franchise